I-ne CO (4933) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
16 Oct, 2026Executive summary
FY2025 net sales rose 8.8% YoY to ¥48.975bn, a record, led by skincare and related products, which grew 221.1%.
Operating profit fell 14.4% to ¥3.88bn, while EBITDA increased 8.3% to ¥5.626bn; acquisition-related amortization weighed on operating profit.
Profit attributable to owners of parent declined 28.9% to ¥2.097bn; comprehensive income fell 16.1% to ¥2.386bn.
Financial highlights
Gross profit increased to ¥28.745bn from ¥24.046bn year over year.
Cost of sales improved to 41.2% of revenue from 46.3%; the 4Q ratio was 38.8%, marking four consecutive quarters of improvement.
Operating cash flow improved to ¥4.058bn from ¥38m; year-end cash and cash equivalents increased to ¥8.531bn from ¥7.270bn.
Online sales grew 41.5% YoY and reached 46% of total sales, up from ~35%.
Outlook and guidance
FY2026 net sales are forecast at ¥52bn–¥54bn; operating profit at ¥0.5bn–¥1bn and EBITDA at ¥1.2bn–¥2.7bn.
Integration efforts are expected to continue at TOUT VERT and Artemis, pursuing further synergies through management expertise and resources.
Logistics cost ratio is expected to improve from FY2026; medium-term labor-cost-ratio improvement is expected from sales growth and increased DX and AI use.
Latest events from I-ne CO
- 9M sales rose 24.6%, while profits fell and FY2026 sales guidance increased.4933
Q3 2026 - H1 sales rose 20.1%, lifting guidance despite cost pressures and a lower full-year profit outlook.4933
Q2 2026 - Q1 revenue rose 22.4%, with profit gains outpacing sales growth; FY guidance was unchanged.4933
Q1 2025 - H1 sales and EBITDA grew as skincare and online gains offset haircare and M&A profit pressure.4933
Q2 2025 - Sales and EBITDA grew, but attributable profit fell amid uneven category performance.4933
Q3 2025 - Q1 sales rose 12.4%, while profit fell amid higher investment and one-time losses.4933
Q1 2026